open access

Vol 43, No 2 (2012)
ORIGINAL RESEARCH ARTICLE
Submitted: 2012-03-14
Published online: 2012-09-01
Get Citation

Porównanie metod ilościowego oznaczania wolnych lekkich łańcuchów (FLC), Hevylite™ (HLC) i immunofiksacji (IFE) w ocenie remisji choroby w szpiczaku plazmocytowym

Maria Kraj, Barbara Kruk1, Andrzej Szczepiński1, Krzysztof Warzocha1
DOI: 10.1016/S0001-5814(12)32007-0
·
Acta Haematol Pol 2012;43(2):122-131.
Affiliations
  1. Instytut Hematologii i Transplantologii, Warszawa, Poland

open access

Vol 43, No 2 (2012)
ORIGINAL RESEARCH ARTICLE
Submitted: 2012-03-14
Published online: 2012-09-01

Abstract

HLC separately measures in pairs light chain types of each intact immunoglobulin (Ig) class generating ratios of monoclonal Ig/non-involved polyclonal Ig concentrations; potentially simplifying assessment of monoclonal protein response. Normalization of FLC ratio is considered higher level of complete remission (CR) in multiple myeloma (MM). To compare IFE, HLC and FLC in assessment of remission we assayed sera from 44 MM patients who underwent autologous stem cell transplantation (ASCT). Of 44 patients in 26 (59%) after ASCT normalization of FLC ratio occurred. In 22 (84.6%) patients with normal FLC ratio also normalization of HLC ratio was noted but in 5 (19%) patients IFE was still positive. Concordance of three tests (IFE negative, HLC ratio normal, FLC normal) was found in 19 (73%) patients. In 21 of 44 (47%) patients after ASCT, normalization of FLC ratio documented sCR. In this group 5 (28%) patients relapsed. Median PFS was 24 months. In patients with CR, VGPR and PR 12 (60%) patients progressed. Median PFS was 12 months. One patient with IgAλ MM, sCR after ASCT and λ FLC clonal escape at relapse and at that time with negative IgAλ IFE and normal IgA HLC ratio illustrates the importance of serum FLC elevation for early detection of clinical relapse, in the absence of any other clinical and laboratory finding. Conclusion. IFE is more sensitive than HLC and FLC assays in detecting residual disease. CR with normalization of HLC and FLC ratios have impact on PFS.

Abstract

HLC separately measures in pairs light chain types of each intact immunoglobulin (Ig) class generating ratios of monoclonal Ig/non-involved polyclonal Ig concentrations; potentially simplifying assessment of monoclonal protein response. Normalization of FLC ratio is considered higher level of complete remission (CR) in multiple myeloma (MM). To compare IFE, HLC and FLC in assessment of remission we assayed sera from 44 MM patients who underwent autologous stem cell transplantation (ASCT). Of 44 patients in 26 (59%) after ASCT normalization of FLC ratio occurred. In 22 (84.6%) patients with normal FLC ratio also normalization of HLC ratio was noted but in 5 (19%) patients IFE was still positive. Concordance of three tests (IFE negative, HLC ratio normal, FLC normal) was found in 19 (73%) patients. In 21 of 44 (47%) patients after ASCT, normalization of FLC ratio documented sCR. In this group 5 (28%) patients relapsed. Median PFS was 24 months. In patients with CR, VGPR and PR 12 (60%) patients progressed. Median PFS was 12 months. One patient with IgAλ MM, sCR after ASCT and λ FLC clonal escape at relapse and at that time with negative IgAλ IFE and normal IgA HLC ratio illustrates the importance of serum FLC elevation for early detection of clinical relapse, in the absence of any other clinical and laboratory finding. Conclusion. IFE is more sensitive than HLC and FLC assays in detecting residual disease. CR with normalization of HLC and FLC ratios have impact on PFS.

Get Citation

Keywords

Heavy/light chain assay; free light chains; multiple myeloma; minimal residual disease; remission; Hevylite; wolne łańcuchy lekkie; szpiczak plazmocytowy; choroba resztkowa; remisja

About this article
Title

Porównanie metod ilościowego oznaczania wolnych lekkich łańcuchów (FLC), Hevylite™ (HLC) i immunofiksacji (IFE) w ocenie remisji choroby w szpiczaku plazmocytowym

Journal

Acta Haematologica Polonica

Issue

Vol 43, No 2 (2012)

Pages

122-131

Published online

2012-09-01

Page views

182

Article views/downloads

233

DOI

10.1016/S0001-5814(12)32007-0

Bibliographic record

Acta Haematol Pol 2012;43(2):122-131.

Keywords

Heavy/light chain assay
free light chains
multiple myeloma
minimal residual disease
remission
Hevylite
wolne łańcuchy lekkie
szpiczak plazmocytowy
choroba resztkowa
remisja

Authors

Maria Kraj
Barbara Kruk
Andrzej Szczepiński
Krzysztof Warzocha

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl